5 Anticonvulsants
Learn how seizure type and individual health factors guide antiseizure medication selection, and review key mechanisms, adverse effects, interactions, and pregnancy-related risks.
Principles of medication selection
are selected by considering seizure type and syndrome together with the person’s other health conditions, adverse-effect risks, interactions, and reproductive plans. Kidney or liver function, age, and pregnancy potential can also affect the choice. Treatment selection is individualized: a broad-spectrum medication is not automatically best for everyone, because its seizure coverage, risks, interactions, and expected benefit must fit the person.
Medication changes should be made with a qualified clinician. Do not stop antiseizure medication abruptly or make unsupervised changes.
Match treatment to seizure type
Frequent brief staring spells with immediate recovery and no other identified seizure types are an example of absence seizures occurring alone. is a commonly used targeted option in that situation. If other generalized seizure types are present, a broader-spectrum medication may be considered instead; the choice depends on the full syndrome and individual factors.
Carbamazepine can worsen absence or myoclonic seizures. This illustrates why medication choice must match the seizure type rather than rely on a general assumption that one medication suits every seizure pattern.
Mechanisms of selected medications
These are principal mechanisms, not complete accounts of every drug’s actions. Mechanisms for some antiseizure medications are not fully understood.
: blocks , a mechanism especially relevant to absence seizures.
: modulates synaptic vesicle protein .
: inhibits voltage-gated sodium channels.
Adverse effects and safe initiation
New irritability or aggression in a person taking may be a medication-related behavioral change. Mood symptoms can also occur. The patient should promptly discuss the change with the prescribing clinician, who can assess its severity and possible causes and review treatment options. Monitor for worsening depression or suicidal thoughts, and do not stop the medication abruptly without medical guidance.
can cause serious skin reactions, including Stevens–Johnson syndrome. A new rash should be reported promptly and medical advice sought. When is started in someone taking , raises concentrations by slightly more than twofold according to prescribing information. The starting dose and increases therefore need to follow the recommended slower schedule.
and medication interactions
has , is strongly protein-bound, and induces drug-metabolizing enzymes. Adding or stopping another medication can therefore change levels or reduce the effectiveness of other medicines.
For example, a drug that inhibits metabolism may raise its concentration and increase toxicity risk. Enzyme induction can reduce levels of some medicines, including hormonal contraceptives. When an interaction is suspected, clinicians may review the full medication list and check levels.
and pregnancy
exposure during pregnancy is associated with major congenital malformations, including neural tube defects, and adverse neurodevelopmental outcomes. Prescribing information says generally should not be used during pregnancy or by people planning pregnancy unless other medications have failed or are unacceptable.
A patient should not stop abruptly after learning they are pregnant, because uncontrolled seizures can also be dangerous. The patient should promptly contact the treating clinician to discuss an individualized plan.